maja kojovic
maja kojovic
Neurology Clinic, University of Ljubljana
Verified email at kclj.si
Title
Cited by
Cited by
Year
Myoclonic disorders: a practical approach for diagnosis and treatment
M Kojovic, C Cordivari, K Bhatia
Therapeutic advances in neurological disorders 4 (1), 47-62, 2011
1712011
Physical precipitating factors in functional movement disorders
I PareÚs, M Kojovic, C Pires, I Rubio-Agusti, TA Saifee, A Sadnicka, ...
Journal of the neurological sciences 338 (1-2), 174-177, 2014
1212014
Believing is perceiving: mismatch between self-report and actigraphy in psychogenic tremor
I PareÚs, TA Saifee, P Kassavetis, M Kojovic, I Rubio-Agusti, JC Rothwell, ...
Brain 135 (1), 117-123, 2012
1172012
Functional reorganization of sensorimotor cortex in early Parkinson disease
M Kojovic, M Bologna, P Kassavetis, N Murase, FJ Palomar, A Berardelli, ...
Neurology 78 (18), 1441-1448, 2012
1092012
Secondary and primary dystonia: pathophysiological differences
M Kojovic, I PareÚs, P Kassavetis, FJ Palomar, P Mir, JT Teo, C Cordivari, ...
Brain 136 (7), 2038-2049, 2013
1012013
Movement disorders in adult patients with classical galactosemia
I Rubio‐Agusti, M Carecchio, KP Bhatia, M Kojovic, I Parees, ...
Movement Disorders 28 (6), 804-810, 2013
652013
Inpatient treatment of functional motor symptoms: a long-term follow-up study
TA Saifee, P Kassavetis, I PareÚs, M Kojovic, L Fisher, L Morton, J Foong, ...
Journal of neurology 259 (9), 1958-1963, 2012
592012
Botulinum toxin injections reduce associative plasticity in patients with primary dystonia
M Kojovic, A Caronni, M Bologna, JC Rothwell, KP Bhatia, MJ Edwards
Movement Disorders 26 (7), 1282-1289, 2011
572011
Functional (psychogenic) symptoms in Parkinson's disease
I PareÚs, TA Saifee, M Kojovic, P Kassavetis, I Rubio‐Agusti, A Sadnicka, ...
Movement Disorders 28 (12), 1622-1627, 2013
492013
C2orf37 mutational spectrum in Woodhouse–Sakati syndrome patients
AM Alazami, SA Schneider, D Bonneau, L Pasquier, M Carecchio, ...
Clinical genetics 78 (6), 585-590, 2010
482010
Transcranial magnetic stimulation follow‐up study in early Parkinson's disease: a decline in compensation with disease progression?
M Kojovic, P Kassavetis, M Bologna, I PareÚs, I Rubio‐Agusti, ...
Movement Disorders 30 (8), 1098-1106, 2015
422015
Developing a tool for remote digital assessment of Parkinson's disease
P Kassavetis, TA Saifee, G Roussos, L Drougkas, M Kojovic, JC Rothwell, ...
Movement disorders clinical practice 3 (1), 59-64, 2016
402016
Atypical parkinsonism and cerebrotendinous xanthomatosis: report of a family with corticobasal syndrome and a literature review
I Rubio‐Agusti, M Kojovic, MJ Edwards, E Murphy, HS Chandrashekar, ...
Movement disorders 27 (14), 1769-1774, 2012
362012
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
M Kojovic, P Mir, I Trender-Gerhard, SA Schneider, I PareÚs, MJ Edwards, ...
Journal of neurology 261 (6), 1080-1089, 2014
352014
All in the blink of an eye: new insight into cerebellar and brainstem function in DYT 1 and DYT 6 dystonia
A Sadnicka, JT Teo, M Kojovic, I PareÚs, TA Saifee, P Kassavetis, ...
European journal of neurology 22 (5), 762-767, 2015
342015
Tremulous cervical dystonia is likely to be familial: clinical characteristics of a large cohort
I Rubio-Agusti, I PareÚs, M Kojovic, M Stamelou, TA Saifee, ...
Parkinsonism & related disorders 19 (6), 634-638, 2013
322013
The syndrome of deafness‐dystonia: clinical and genetic heterogeneity
M Kojovic, I PareÚs, T Lampreia, K Pienczk‐Reclawowicz, G Xiromerisiou, ...
Movement disorders 28 (6), 795-803, 2013
302013
Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family
M Kojovic, UM Sheerin, I Rubio-Agusti, A Saha, J Bras, V Gibbons, ...
Movement disorders 27 (14), 1829, 2012
302012
Reversal of practice-related effects on corticospinal excitability has no immediate effect on behavioral outcome
M Bologna, L Rocchi, G Paparella, A Nardella, PL Voti, A Conte, ...
Brain stimulation 8 (3), 603-612, 2015
262015
Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
S Reden╣ek, D Flisar, M KojoviŠ, M GregoriŔ Kramberger, D Georgiev, ...
Frontiers in pharmacology 10, 8, 2019
202019
The system can't perform the operation now. Try again later.
Articles 1–20